1. Structural analyses reveal two distinct families of nucleoside phosphorylases;Pugmire;Biochem. J.,2002
2. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity;Leyva;Cancer Res.,1984
3. Clinical and pharmacokinetic studies of prolonged administration of high-dose uridine intended for rescue from 5-fluorouracil toxicity;van Groeningen;Cancer Treat. Rep.,1986
4. Modulation of 5-fluorouracil host toxicity by 5-(benzyloxybenzyl)barbituric acid acyclonucleoside, a uridine phosphorylase inhibitor, and 2′3′5′-tri-O-acetyluridine, a prodrug of uridine;Ashour;Biochem. Pharmacol.,2000
5. Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor;Pizzorno;Clin. Cancer Res.,1998